Case Summary:

Our EB1-A (Alien of Extraordinary Ability) client from India is one of the few leading neurophysiology experts in neuroscience. He has achieved a consistent and notable record of success and influence in this area of study and he is especially well-known for his research identifying age-related biomarkers of neuroinflammatory diseases, such as multiple sclerosis. Thus, when he said that he wanted to apply for an EB1-A visa, our team first made sure to explain the visa category to him and then proceed with the formality of signing the retainer.

The next step was to collect data for his petition, from his CVs, transcripts, certificates, etc. This yielded the following information:

• The field has recognized our client’s authority by inviting him to review and evaluate the work of his peers no fewer than 13 times.
• In addition to directly advancing neurology through his original research and peer review service, our client has actively engaged his peers in the field of neuroscience by authoring and co-authoring 16 peer-reviewed articles that have been published in international journals. Moreover, his papers have been published in some of the most discerning, high-impact journals in his field.
• He is particularly well-known for his contributions to the identification of age-related biomarkers of neuroinflammatory diseases, such as multiple sclerosis.
• These publications have been cited 300 times by researchers in at least 33 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of neuroscience.
• Additionally, his study has been supported by funding from the National Institute of Child Health and Human Development (NICHD). The NICHD funds projects that promote human development throughout the entire life process, particularly research aimed at expanding the understanding of disabilities and other important events that occur during pregnancy and early childhood. As a result, the NICHD’s support of our client’s research clearly indicates its value to these causes and the nation more broadly.
• At last but not least, we also got 4 letters supporting his work in the area from other experts in the area. One of these recommenders supported his work in the following words:

“Autism is diagnosed through developmental history and behavior because there is no medical detection for autism. [The client’s] research on this topic developed a unique imaging technique that looked at abnormal brain protein synthesis to identify an imaging biomarker for autism and its severity. [The client’s] discovery of this imaging biomarker identifies underlying mechanisms for autism and creates new therapeutic interventions for autism that correct abnormal protein synthesis and ameliorate the burden of autism spectrum disorders in the U.S.”

Thus, the approval of his case was the result of a collective effort on our and our client’s part. We are glad to have aided him in this journey and we wish him great success in future endeavors.